CEBPA MUTATION DETECTION Test
Components: CEBPA MUTATION DETECTION Test
Price: 1680.0 AED
Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery: Sample Daily by 11 am; Report 10 Working days
Method: PCR
Test type: Leukemia
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details
The CEBPA mutation detection test is a diagnostic test used to identify mutations in the CEBPA gene. The CEBPA gene encodes for a transcription factor that plays a crucial role in the development and maturation of myeloid cells, which are a type of white blood cell.
Mutations in the CEBPA gene have been associated with various types of leukemia, particularly acute myeloid leukemia (AML). These mutations can affect the normal function of the CEBPA protein and disrupt the regulation of genes involved in cell growth and differentiation, leading to the development of cancer.
The CEBPA mutation detection test typically involves analyzing a sample of the patient’s blood or bone marrow for specific mutations in the CEBPA gene. This can be done using various techniques, such as polymerase chain reaction (PCR) or DNA sequencing.
Identifying CEBPA mutations can be important for guiding treatment decisions in patients with AML. Certain CEBPA mutations are associated with better outcomes and may influence the choice of therapy, such as the use of targeted therapies or stem cell transplantation.
Overall, the CEBPA mutation detection test is a valuable tool in the diagnosis and management of AML and other leukemias associated with CEBPA gene mutations. It helps to provide personalized treatment options and improve patient outcomes.
Test Name | CEBPA MUTATION DETECTION Test |
---|---|
Components | |
Price | 1680.0 AED |
Sample Condition | 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Report Delivery | Sample Daily by11 am;Report 10 Working days |
Method | PCR |
Test type | Leukemia |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Test Details |
The CEBPA mutation detection test is a diagnostic test used to identify mutations in the CEBPA gene. The CEBPA gene encodes for a transcription factor that plays a crucial role in the development and maturation of myeloid cells, which are a type of white blood cell. Mutations in the CEBPA gene have been associated with various types of leukemia, particularly acute myeloid leukemia (AML). These mutations can affect the normal function of the CEBPA protein and disrupt the regulation of genes involved in cell growth and differentiation, leading to the development of cancer. The CEBPA mutation detection test typically involves analyzing a sample of the patient’s blood or bone marrow for specific mutations in the CEBPA gene. This can be done using various techniques, such as polymerase chain reaction (PCR) or DNA sequencing. Identifying CEBPA mutations can be important for guiding treatment decisions in patients with AML. Certain CEBPA mutations are associated with better outcomes and may influence the choice of therapy, such as the use of targeted therapies or stem cell transplantation. Overall, the CEBPA mutation detection test is a valuable tool in the diagnosis and management of AML and other leukemias associated with CEBPA gene mutations. It helps to provide personalized treatment options and improve patient outcomes. |